AJMC April 8, 2025
Key Takeaways
- Tariffs on imports could increase costs and worsen shortages of pharmaceuticals and medical supplies in the US healthcare system.
- The US heavily relies on pharmaceutical imports, with China being a major producer of active pharmaceutical ingredients.
- Generic drug manufacturers may exit the market due to financial strain, exacerbating drug shortages and increasing healthcare costs.
- Industry groups are pushing for tariff exemptions and domestic manufacturing policies, but face challenges like high costs and extended timelines.
Taxing imports to the US could spell major consequences for health care prices, innovation, and access, as a great amount of medical supplies and ingredients are manufactured overseas.
The Trump administration has imposed a litany of tariffs for almost all imports to...
Today's Sponsors
Today's Sponsor